US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist
  • 0.204
  • -0.016-7.27%
Close Jun 14 16:00 ET
  • 0.209
  • +0.005+2.35%
Post 19:22 ET
13.09MMarket Cap-248P/E (TTM)

Calidi Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Calidi Biotherapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.20

-11.13%
Analyst Rating

Buy

May 31, 2024

Calidi Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Calidi Biotherapeutics Earnings Reports

  • Calidi Biotherapeutics | 10-Q: Quarterly report

    May 14 17:01 ET

  • Calidi Biotherapeutics | 10-K: Annual report

    Mar 15 17:37 ET

  • Calidi Biotherapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:16 ET

  • First Light Acquisition Group, Inc | 10-Q: Q2 2023 Earnings Report

    Aug 21, 2023 17:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg